Metrics

What Metrics does

Metrics Contract Services is a pharmaceutical contract development and manufacturing organization (CDMO) founded in 2002 and headquartered in Greenville, North Carolina, specializing in integrated oral solid formulation development, manufacturing, and packaging. The company has built particular depth in handling highly potent compounds, with over 20 years of specialized potent-handling experience and a state-of-the-art containment facility designed for fit-for-scale production of small to mid-size batches. Following its 2022 acquisition by Catalent, Inc. for $475 million, Metrics now operates as a business unit within Catalent's Oral Dose segment, contributing its high-potency capabilities and Greenville capacity to Catalent's global oral solids network that also includes flagship sites in Winchester, KY and Schorndorf, Germany.

The company's service offering spans the full oral solid development lifecycle — from API optimization, particle size optimization, and formulation services, through drug delivery technology and final dose form design, into clinical supply solutions. Core technical capabilities include integrated analytical, development, manufacturing, and clinical supply operations for highly potent products, with the Greenville facility's containment infrastructure serving as the differentiating technical asset. Metrics complements rather than overlaps with Catalent's large-scale oral solids manufacturing footprint, positioning the business to serve customers with small-to-mid-size batch needs and specialized potent compound requirements.

Metrics operates on a contract manufacturing revenue model, providing services through direct B2B agreements with pharmaceutical companies. Pricing is structured under confidential contract manufacturing agreements rather than published rate cards. The company serves a single vertical segment — pharmaceutical enterprises — and does not engage in consumer-facing distribution. As a wholly-owned subsidiary of publicly-traded Catalent (NYSE: CTLT), Metrics' standalone revenue and customer roster are not separately disclosed, and its operations have been integrated into Catalent's broader oral dose portfolio and clinical supply network post-acquisition.

Name

Metrics

Legal name

Metrics Contract Services

Website

https://metricsinc.com

Company type

Private

Founded year

2002

Operating status

Acquired

Headcount range

251–500 employees

Short description

Metrics Contract Services is a pharmaceutical CDMO specializing in oral solid formulation development, manufacturing, and packaging, with deep expertise in highly potent compound handling. Founded in 2002 in Greenville, North Carolina, it was acquired by Catalent in 2022 for $475 million and now operates as a unit within Catalent's Oral Dose segment.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Development & Manufacturing (CDMO)

NAICS

Scientific Research and Development Services (5417)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Small-Molecule API & Intermediates CDMO (HLAGABAA)

Keywords

• Oral solid formulation
• Pharmaceutical contract manufacturing
• Potent compound handling
• Drug development services
• Clinical supply solutions

Headquarters

HQ city

Greenville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Pharmaceutical contract development and manufacturing services including oral solid formulation, potent compound handling, and clinical supply solutions.

Distribution channels1 record

Core offering

Metrics Contract Services is a CDMO providing integrated oral solid formulation development, manufacturing, and packaging services from its Greenville, North Carolina facility, with specialized expertise in handling highly potent pharmaceutical compounds. Services span API optimization, particle size optimization, formulation development, drug delivery technology, final dose form design, and clinical supply solutions for small to mid-size batches.

Product overview

Metrics Contract Services was a standalone pharmaceutical contract services provider that operated as a single unified offering focused on oral solid dose development and manufacturing. The company was acquired by Catalent for $475 million and its operations and capabilities have been integrated into Catalent's oral dose portfolio. The core offering centered on the Greenville, North Carolina facility providing end-to-end solutions from API optimization and particle size optimization to formulation services, drug delivery technology, and final dose form design services.

Differentiator

Problem solved

Functional benefit

Products and services

• Oral Solid Formulation Development and Manufacturing Services Integrated development, manufacturing, and packaging services for oral solid dosage pharmaceutical products, delivered from the Greenville, NC facility for pharmaceutical companies requiring end-to-end oral dose support.
• Highly Potent Compound Handling Services Specialized contract services for development and manufacturing of pharmaceutical products containing highly potent active pharmaceutical ingredients, with containment expertise and integrated analytical, development, manufacturing, and clinical supply capabilities.
• API Optimization and Drug Delivery Technology Services Early-stage pharmaceutical development services spanning API optimization, particle size optimization, formulation services, drug delivery technology, and final dose form design to support customers from earliest drug development through to clinic and market.
• Clinical Supply Solutions Clinical supply services integrated with oral dose development and manufacturing, supporting pharmaceutical customers' programs from clinical stages through commercial readiness.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Alcami Corporation: Alcami is a US-based CDMO providing oral solid dose development, manufacturing, and packaging services with focus on small-to-mid-size pharma and biotech sponsors. It is a direct competitor to Metrics in the small-to-mid-size batch segment.
• Cambrex: Cambrex is a global small-molecule CDMO offering API and finished dosage form development and manufacturing. It serves the same pharmaceutical customer base as Metrics with overlapping oral solid dose capabilities.
• Pfizer CentreOne: Pfizer CentreOne is the contract manufacturing arm of Pfizer offering oral solid dose commercial and development services to external pharma sponsors. It directly competes with Metrics for outsourced oral solid formulation work.
• Thermo Fisher Scientific (Patheon): Thermo Fisher operates the Patheon CDMO business, one of the largest global pharmaceutical contract development and manufacturing organizations with deep oral solid dose capabilities. Patheon competes directly with Metrics for commercial-scale and development-stage oral solid formulation work across pharma sponsors.
• WuXi STA (WuXi AppTec): WuXi STA is the CDMO arm of WuXi AppTec, offering end-to-end oral solid dose development and manufacturing services globally. It is one of the largest Asia-headquartered CDMOs and a direct competitor for oral solid formulation outsourcing work.
• Aenova Group: Aenova is one of the largest CDMOs in Europe, with strong oral solid dose capabilities across development, manufacturing, and packaging. It competes with Metrics for both small-batch and commercial-scale oral solid dose contracts.
• Curia (formerly AMRI): Curia operates a global CDMO business built on the former AMRI platform, providing oral solid dose contract development and manufacturing services. It overlaps with Metrics across small-molecule oral solid formulation and packaging capabilities.
• Piramal Pharma Solutions: Piramal Pharma Solutions is a global CDMO offering integrated drug development and manufacturing services including oral solid dose formulation. Its scale, FDA-inspected facilities, and potent handling capabilities make it a direct competitor to Metrics in the small-to-mid-size batch segment.

Broad incumbents

• Catalent, Inc. Catalent is the parent company that acquired Metrics Contract Services for $475M in 2022 and now operates it as a business unit within its Oral Dose segment. Catalent is the largest global oral solid dose CDMO with flagship sites in Winchester KY and Schorndorf Germany, and is the most directly relevant reference point for Metrics' competitive context.

Emerging players

• Eurofins CDMO: Eurofins has expanded into pharmaceutical CDMO services including oral solid dose development and manufacturing. It is a broader-lifecycle scientific services provider that has grown into adjacent CDMO capabilities overlapping with Metrics.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/metrics-inc-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metrics